ישראל -
עברית -
Ministry of Health
קסיגדו 5 מג 500 מג xr
astrazeneca (israel) ltd - dapagliflozin propanediol; metformin hydrochloride - טבליות עם שחרור נרחב - metformin hydrochloride 502.61 mg; dapagliflozin propanediol 6.150 mg - metformin and dapagliflozin
ישראל -
עברית -
Ministry of Health
ג'יג'י מי פנים קמומיל אזולן לעור יבש
שולמית קוסמטיקה ואירוסול (1999) בעמ - טיפוח העור
ישראל -
עברית -
Ministry of Health
אלאודם פילינג ג'ל אזולן
אנה לוטן בעמ - ריכוך והסרה קלה של התאים המתים, פילינג
ישראל -
עברית -
Ministry of Health
קלופידוגרל טבע
teva israel ltd - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or